| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $405.4M | -2.3% |
| Cost of Revenue | $202.2M | -3.5% |
| Gross Profit | $203.2M | -1.1% |
| R&D Expense | $600K | +0.0% |
| SG&A Expense | $125.0M | -3.9% |
| Operating Income | $82.6M | +9.4% |
| Pre-tax Income | $61.7M | +285.4% |
| Income Tax | $23.9M | +392.9% |
| Net Income | $38.5M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $117.9M | +10.8% |
| Accounts Receivable | $10.0M | +19.2% |
| Inventory | $99.0M | -17.5% |
| Current Assets | $267.6M | +3.9% |
| Total Assets | $569.4M | -0.5% |
| Current Liabilities | $100.3M | +142.5% |
| Long-term Debt | $307.1M | -24.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $66.9M | +120.9% |
| Capital Expenditures | $5.7M | -25.7% |
| Investing Cash Flow | -$5.9M | +68.6% |
| Financing Cash Flow | -$49.5M | -14.3% |
| Free Cash Flow | $61.2M | +170.8% |
| +230.4% |
| EPS (Basic) | $2.19 | +236.9% |
| EPS (Diluted) | $2.01 | +214.1% |
| Total Liabilities |
| $417.4M |
| -9.0% |
| Stockholders' Equity | $151.0M | +35.2% |